SANOFI : Gets a Buy rating from Jefferies

Published on 05/06/2025 at 16:57

MarketScreener with dpa-AFX Analyser

Benjamin Jackson from Jefferies retains his positive opinion on the stock with a Buy rating. The target price remains set at EUR 120.

Latest news about Sanofi

Thermo Fisher Scientific Inc. entered into an agreement to acquire Steriles Manufacturing Site in Ridgefield, New Jersey of Sanofi.	09:10pm	CI
Thermo Fisher acquires Sanofi's New Jersey manufacturing site	07:15pm	RE
Thermo Fisher Scientific Expands Partnership with Sanofi	06:37pm	DJ
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing	06:35pm	CI
Price Data Softens Tariff Tensions Rise	06:26pm
Thermo Fisher, Sanofi Expand Partnership With New Jersey Facility Deal	06:15pm	MT
Thermo Fisher Scientific and Sanofi expand strategic partnership to enable additional U.S. drug product manufacturing	05:39pm	RE
Sanofi Geographic Atrophy Treatment Gets FDA's Fast Track Designation	04:13pm	DJ
Sanofi: fast track designation in GA due to AMD	11:48am
Sanofi's Sar446597 Earns Fast Track Designation in the US for Geographic Atrophy Due Toage-Related Macular Debutation	11:20am	CI
Sanofi's Atrophy Treatment Receives US Fast-track Designation	10:49am	MT
Sanofi's SAR446597 earns fast track designation in US for geographic atrophy due to age-related macular degeneration	10:39am	RE
SANOFI : UBS reiterates its Buy rating	11/07	ZD
Delaware Supreme Court sides with Zantac drugmakers over cancer evidence	11/07	RE
Delaware Supreme Court sides with Zantac drugmakers over evidence	11/07	RE
Nurix Therapeutics Fiscal Q2 Loss Narrows, Revenue More Than Triples; Shares Surge Premarket	10/07	MT
SANOFI : UBS maintains a Buy rating	08/07	ZD
SANOFI : Goldman Sachs reiterates its Neutral rating	03/07	ZD
Berenberg Keeps Sanofi at Buy on Expanding Pipeline Optionality	03/07	MT
SANOFI : Gets a Buy rating from Berenberg	03/07	ZD
AlphaValue/Baader Europe Cuts Sanofi Price Target Amid Pipeline Setbacks, Leadership Concerns	02/07	MT
SANOFI : Barclays keeps its Buy rating	02/07	ZD
SANOFI : JP Morgan remains Neutral	02/07	ZD
SANOFI : Pipeline disappointments may push out the CEO	01/07
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	01/07	MT